PubMed Sikiric, P., Separovic, J., Anic, T., Buljat, G., Mikus, D., Seiwerth, S., Grabarevic, Z., Stancic-Rokotov, D., Pigac, B., Hanzevacki, M., Marovic, A., Rucman, R., Petek, M., Ziger, T., Sebecic, B., Zoricic, I., Turkovic, B., Aralica, G., Perovic, D., Duplancic, B., Lovric-Bencic, M., & Rotkvic, I
Ipamorelin is a synthetic pentapeptide growth hormone-releasing peptide (GHRP) and selective agonist of the ghrelin receptor (GHS-R1a), originally developed by Novo Nordisk in Denmark and first characterised in a landmark 1998 paper in the European Journal of Endocrinology by Raun and colleagues
High-Purity Research Grade : Cagrilintide is manufactured to a high purity (typically 9899% by HPLC), with identity verified by techniques such as LC-MS
This guarantees that what you receive is always safe and effective
Antigen Details Structure Monomer Distribution Astrocytes, hepatocytes, microglia, intestinal smooth muscle, myoblast, NK cells Function IGF-I induces mitogenesis, proliferation, growth, differentiation, and angiogenesis